Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 53.

Moch, H; Bonsib, S M; Delahunt, B; Eble, J N; Egevad, L; Grignon, D J; Linehan, W M; Reuter, V E; Srigley, J R; Sulser, T; Tan, P H (2016). Clear cell renal cell carcinoma. In: Moch, H; Humphrey, P A; Ulbright, T M; Reuter, V E. WHO classification of tumours of the urinary system and male genital organs. Lyon: International Agency for Research on Cancer (IARC), 18-21.

Fankhauser, C D; Curioni-Fontecedro, A; Allmann, V; Beyer, J; Tischler, V; Sulser, T; Moch, H; Bode, P K (2015). Frequent PD-L1 expression in testicular germ cell tumors. British Journal of Cancer, 113(3):411-413.

Huber, F; Montani, M; Sulser, T; Jaggi, R; Wild, P; Moch, H; Gevensleben, H; Schmid, M; Wyder, S; Kristiansen, G (2015). Comprehensive validation of published immunohistochemical prognostic biomarkers of prostate cancer-what has gone wrong? A blueprint for the way forward in biomarker studies. British Journal of Cancer, 112:140-148.

Wyler, L; Napoli, C U; Ingold, B; Sulser, T; Heikenwälder, M; Schraml, P; Moch, H (2014). Brain metastasis in renal cancer patients: metastatic pattern, tumour-associated macrophages and chemokine/chemoreceptor expression. British Journal of Cancer, 110(3):686-694.

Strebel, R T; Schmidt, C; Beatrice, J; Sulser, T (2013). Chronic scrotal pain syndrome (CSPS): the widespread use of antibiotics is not justified. Andrology, 1(1):155-159.

Poyet, C; Hof, D; Sulser, T; Müntener, M (2012). Artificial prostate-specific antigen persistence after radical prostatectomy. Journal of Clinical Oncology, 30(5):e62-3.

Reiner, C S; Goetti, R; Eberli, D; Klotz, E; Boss, A; Pfammatter, T; Frauenfelder, T; Moch, H; Sulser, T; Alkadhi, H (2012). CT perfusion of renal cell carcinoma: Impact of volume coverage on quantitative analysis. Investigative Radiology, 47(1):33-40.

Bachmann, A; Sulser, T; Zumbé, J (2012). Perineale Schmerzen aus urologischer Sicht. In: Lange, J; Mölle, B; Girona, J. Chrirurgische Proktologie. Heidelberg: Springer, 425-430.

Bachmann, A; Sulser, T; Zumbé, J (2012). Urologische Massnahmen bei koloproktologischen Eingriffen. In: Lange, J; Mölle, B; Girona, J. Chirurgische Proktologie. Heidelberg: Springer, 443-457.

Tremp, M; Salemi, S; Gobet, R; Sulser, T; Eberli, D (2011). Adipose-derived stem cells for tissue engineering applications. In: Eberli, D. Regenerative Medicine and Tissue Engineering. Cells and Biomaterials. Rijeka, Croatia: InTech, 179-194.

Cathomas, R; Berthold, D; Gillessen, S; Recker, F; Stenner, F; Strebel, R T; Sulser, T; Zwahlen, D R; Schmid, H P (2011). Das Prostatakarzinom im Wandel. Grundpfeiler der Diagnostik, Behandlung und Interdisziplinarität. Swiss Medical Forum, 11(43):759-763.

Tremp, M; Hefermehl, L; Largo, R; Knönagel, H; Sulser, T; Eberli, D (2011). Electrosurgery in urology: recent advances. Expert Review of Medical Devices, 8(5):597-605.

Fritzsche, F R; Hasler, A; Bode, P K; Adams, H; Seifert, H H; Sulser, T; Moch, H; Barghorn, A; Kristiansen, G (2011). Expression of histone deacetylases 1, 2 and 3 in histological subtypes of testicular germ cell tumours. Histology and Histopathology, 26(12):1555-1561.

Zecha, H; Schmid, H P; Tschopp, A; Sulser, T; Engeler, D S (2011). High incidence of independent second malignancies after non-muscle-invasive bladder cancer. Scandinavian Journal of Urology and Nephrology, 45(4):245-250.

Mortezavi, A; Hermanns, T; Seifert, H H; Baumgartner, M; Provenzano, M; Sulser, T; Burger, M; Montani, M; Ikenberg, K; Hofstaedter, F; Hartmann, A; Jaggi, R; Moch, H; Kristiansen, G; Wild, P J (2011). KPNA2 expression is an independent adverse predictor of biochemical recurrence after radical prostatectomy. Clinical Cancer Research, 17(5):1111-1121.

Hermanns, T; Strebel, D D; Hefermehl, L J; Gross, O; Mortezavi, A; Müller, A; Eberli, D; Müntener, M; Michel, M S; Meier, A H; Sulser, T; Seifert, H H (2011). Lithium triborate laser vaporization of the prostate using the 120 w, high performance system laser: high performance all the way? The Journal of Urology, 185(6):2241-2247.

Morra, L; Rechsteiner, M; Casagrande, S; Duc Luu, V; Santimaria, R; Diener, P A; Sulser, T; Kristiansen, G; Schraml, P; Moch, H; Soltermann, A (2011). Relevance of periostin splice variants in renal cell carcinoma. American Journal of Pathology, 179(3):1513-1521.

Eberli, D; Hefermehl, L J; Müller, A; Sulser, T; Knönagel, H (2011). Thermal spread of vessel-sealing devices evaluated in a clinically relevant in vitro model. Urologia Internationalis, 86(4):476-482.

Rechsteiner, M P; von Teichman, A; Nowicka, A; Sulser, T; Schraml, P; Moch, H (2011). VHL gene mutations and their effects on hypoxia inducible factor HIF{alpha}: Identification of potential driver and passenger mutations. Cancer Research, 71(16):5500-5511.

Nicoletti, J; Kuster, S; Sulser, T; Zbinden, R; Ruef, C; Ledergerber, B; Weber, R (2010). Risk factors for urinary tract infections due to ciprofloxacin-resistant Escherichia coli in a tertiary care urology department in Switzerland. Swiss Medical Weekly, (140):w13059.

Eberli, D; Tremp, M; Hefermehl, L; Sulser, T; Knönagel, H (2010). The benefits of electrothermal tissue sealing systems in urological surgery. Hospital healthcare Europe. Theatre & surgery:21-24.

Tremp, M; Hafner, J; Sulser, T; Müntener, M (2010). Intraurethral Imiquimod for Extensive Urethral Genital Warts (Condylomata Acuminata). BJU International:online.

Murphy, D G; Bjartell, A; Ficarra, V; Graefen, M; Haese, A; Montironi, R; Montorsi, F; Moul, J W; Novara, G; Sauter, G; Sulser, T; van der Poel, H (2010). Downsides of robot-assisted laparoscopic radical prostatectomy: limitations and complications. European Urology, 57(5):735-746.

Eberli, D; Chassot, P-G; Sulser, T; Samama, C M; Mantz, J; Delabays, A; Spahn, D R (2010). Urological Surgery and Antiplatelet Drugs After Cardiac and Cerebrovascular Accidents. The Journal of Urology, 183(6):2128-2136.

Horst, M; Madduri, S; Gobet, R; Sulser, T; Hall, H; Eberli, D (2010). Scaffolds for the engineering of functional bladder tissues. In: Eberli, D. Tissue Engineering. Vukovar, Croatia: In-Teh, 119-140.

Hefermehl, L; Elke, B; Sulser, T (2010). Das Prostatakarzinom. Praxis, 99(3):149-58.

Müntener, M; Kunz, U; Eichler, K; Puhan, Milo A; Schmid, D M; Sulser, T; Strebel, R T (2010). Lowering the PSA threshold for prostate biopsy from 4 to 2.5 ng/ml: influence on cancer characteristics and number of men needed to biopt. Urologia internationalis, 84(2):141-146.

Ikenberg, K; Fritzsche, F R; Zuerrer-Haerdi, U; Hofmann, I; Hermanns, T; Seifert, H; Müntener, M; Provenzano, M; Sulser, T; Behnke, S; Gerhardt, J; Mortezavi, A; Wild, P; Hofstädter, F; Burger, M; Moch, H; Kristiansen, G (2010). Insulin-like growth factor II mRNA binding protein 3 (IMP3) is overexpressed in prostate cancer and correlates with higher Gleason scores. BMC Cancer, 10:341.

Müntener, M; Kunz, U; Eichler, K; Puhan, Milo A; Schmid, D M; Sulser, T; Strebel, R T (2010). Lowering the PSA threshold for prostate biopsy from 4 to 2.5 ng/ml: influence on cancer characteristics and number of men needed to biopt. Urologia internationalis, 84(2):141-146.

Dahinden, C; Ingold, B; Wild, P; Boysen, G; Luu, V D; Montani, M; Kristiansen, G; Sulser, T; Bühlmann, P; Moch, H; Schraml, P (2010). Mining tissue microarray data to uncover combinations of biomarker expression patterns that improve intermediate staging and grading of clear cell renal cell cancer. Clinical Cancer Research, 16(1):88-98.

Horst, M; Madduri, S; Gobet, R; Sulser, T; Hall, H; Eberli, D (2010). Scaffold Characteristics for Functional Hollow Organ regeneration. In: Taubert, A. Advances in Biomaterials. Basel: MDPI Publishing, 241-263.

Groebli Bolleter, R; Sulser, T; Müntener, M (2009). Urologische Nierensteinbehandlung. Praxis, 98(25):1517-1523.

Hermanns, T; Sauermann, P; Rufibach, K; Frauenfelder, T; Sulser, T; Strebel, R T (2009). Is There a Role for Tamsulosin in the Treatment of Distal Ureteral Stones of 7mm or Less? Results of a Randomised, Double-Blind, Placebo-Controlled Trial. European Urology, 56(3):407-412.

Wild, P J; Fuchs, T; Stoehr, R; Zimmermann, D; Frigerio, S; Padberg, B; Steiner, I; Zwarthoff, E C; Burger, M; Denzinger, S; Hofstaedter, F; Kristiansen, G; Hermanns, T; Seifert, H H; Provenzano, M; Sulser, T; Roth, V; Buhmann, J M; Moch, H; Hartmann, A (2009). Detection of Urothelial Bladder Cancer Cells in Voided Urine Can Be Improved by a Combination of Cytology and Standardized Microsatellite Analysis. Cancer Epidemiology Biomarkers & Prevention, 18(6):1798-1806.

Feicke, A; Baumgartner, M; Talimi, S; Schmid, D M; Seifert, H H; Müntener, M; Fatzer, M; Sulser, T; Strebel, R T (2009). Robotic-assisted laparoscopic extended pelvic lymph node dissection for prostate cancer: surgical technique and experience with the first 99 cases. European Urology, 55(4):876-884.

Umbehr, M; Bachmann, L M; Held, U; Kessler, T M; Sulser, T; Weishaupt, D; Kurhanewicz, J; Steurer, J (2009). Combined magnetic resonance imaging and magnetic resonance spectroscopy imaging in the diagnosis of prostate cancer: a systematic review and meta-analysis. European Urology, 55(3):575-591.

Hermanns, T; Sulser, T; Fatzer, M; Baumgartner, M K; Rey, J M; Sigrist, M W; Seifert, H H (2009). Laser fibre deterioration and loss of power output during photo-selective 80-W potassium-titanyl-phosphate laser vaporisation of the prostate. European Urology, 55(3):679-686.

Hermanns, T; Sulser, T; Hefermehl, L; Strebel, D; Michel, M S; Müntener, M; Meier, A H; Seifert, H H (2009). Loss of power output and laser fibre degradation during 120 watt lithium-triborate HPS laser vaporisation of the prostate. In: SPIE Photonics West 2009, San Jose, California, USA, 24 January 2009 - 29 January 2009.

Tremp, M; Sulser, T; Seifert, H H (2009). Delayed infection of a pelvic lymphocele following robotic radical prostatectomy and pelvic lymphadenectomy: two cases. Urologia internationalis, 83(4):479-481.

Sørensen, K D; Wild, P J; Mortezavi, A; Adolf, K; Tørring, N; Heebøll, S; Ulhøi, B P; Ottosen, P; Sulser, T; Hermanns, T; Moch, H; Borre, M; Ørntoft, T F; Dyrskjøt, L (2009). Genetic and epigenetic SLC18A2 silencing in prostate cancer is an independent adverse predictor of biochemical recurrence after radical prostatectomy. Clinical Cancer Research, 15(4):1400-1410.

Imkamp, F; Herrmann, T; Rassweiler, J; Sulser, T; Stolzenburg, J U; Rabenalt, R; Jonas, U; Burchardt, M (2009). Laparoscopy in German Urology: Changing Acceptance among Urologists. European Urology, 56(6):1074-1081.

Luu, V D; Boysen, G; Struckmann, K; Casagrande, S; von Teichman, A; Wild, P J; Sulser, T; Schraml, P; Moch, H (2009). Loss of VHL and hypoxia provokes PAX2 up-regulation in clear cell renal cell carcinoma. Clinical Cancer Research, 15(10):3297-3304.

Moch, H; Artibani, W; Delahunt, B; Ficarra, V; Knuechel, R; Montorsi, F; Patard, J J; Stief, C G; Sulser, T; Wild, P J (2009). Reassessing the current UICC/AJCC TNM staging for renal cell carcinoma. European Urology, 56(4):636-643.

Savic, S; Zlobec, I; Thalmann, G N; Engeler, D; Schmauss, M; Lehmann, K; Mattarelli, G; Eichenberger, T; Dalquen, P; Spieler, P; Schoenegg, R; Gasser, T C; Sulser, T; Forster, T; Zellweger, T; Casella, R; Bubendorf, L (2009). The prognostic value of cytology and fluorescence in situ hybridization in the follow-up of nonmuscle-invasive bladder cancer after intravesical Bacillus Calmette-Guérin therapy. International Journal of Cancer, 124(12):2899-2904.

Strebel, R T; Müntener, M; Sulser, T (2008). Intraoperative complications of laparoscopic adrenalectomy. World Journal of Urology, 26(6):555-560.

Ruszat, R; Wyler, S F; Gürke, L; Gambazzi, F; Ebinger, N; Steiger, J; Sulser, T; Gasser, C; Bachmann, A (2008). Endoscopic management of bisected hemidiaphragm during retroperitoneoscopic donor nephrectomy. Urology, 72(5):1185 e1-1185e3.

Baumgartner, M K; Hermanns, T; Cohen, A; Schmid, D M; Seifert, B; Sulser, T; Strebel, R T (2008). Patients' knowledge about risk factors for erectile dysfunction is poor. Journal of Sexual Medicine, 5(10):2399-2404.

Feder-Mengus, C; Wyler, S; Hudolin, T; Ruszat, R; Bubendorf, L; Chiarugi, A; Pittelli, M; Weber, W; Bachmann, A; Gasser, T C; Sulser, T; Heberer, M; Spagnoli, G C; Provenzano, M (2008). High expression of indoleamine 2,3-dioxygenase gene in prostate cancer. European Journal of Cancer, 44(15):2266-2275.

Seifert, H H; Hermanns, T; Sulser, T (2008). Die Greenlight-Laservaporisation der Prostata zur Therapie des benignen Prostatasyndroms: Entwicklung und Stellenwert. Urologe Ausgabe, 47(8):964-968.

Schmid, D M; Roy, S; Sulser, T; Scheiner, D (2008). Prospects and limitations of treatment with botulinum neurotoxin type A for patients with refractory idiopathic detrusor overactivity. BJU International, 102(Suppl ):7-10.

Umbehr, M; Kessler, T M; Sulser, T; Kristiansen, G; Probst, N; Steurer, J; Bachmann, L M (2008). ProCOC: the prostate cancer outcomes cohort study. BMC Urology, 8:9.

Kim, M J; Bachmann, A; Mihatsch, M J; Ruszat, R; Sulser, T; Mayr, M (2008). Acute renal failure after continuous flow irrigation in patients treated with potassium-titanyl-phosphate laser vaporization of prostate. American Journal of Kidney Diseases, 51(4):e19-e24.

Stolzmann, P; Scheffel, H; Rentsch, K; Schertler, T; Frauenfelder, T; Leschka, S; Sulser, T; Marincek, B; Alkadhi, H (2008). Dual-energy computed tomography for the differentiation of uric acid stones: ex vivo performance evaluation. Urological Research, 36(3-4):133-138.

This list was generated on Mon Nov 20 02:21:42 2017 CET.